Markers of T2-airway inflammation in patients with chronic obstructive pulmonary disease
Forty percent of patients with COPD without concomitant asthma have markers of T2-airway inflammation in a real clinical practice. The most frequent marker was blood Eos≥150 cell/μl that was associated with rate of COPD exacerbation. Frequency of concomitant T2-diseases (allergic rhinitis, nasal polyps, atopic dermatitis) was low.
Authors
- Antonina Znakhurenko
- Galina Sergeeva (ORCID: https://orcid.org/0000-0003-1544-4336)
- Alexander Emelyanov (ORCID: https://orcid.org/0000-0002-8574-6869)
- E. V. Leshenkova (ORCID: https://orcid.org/0000-0003-4616-3166)
Institutions
- North-Western State Medical University named after I.I. Mechnikov (RU)
Publication Details
- Journal
- Terapevticheskii arkhiv
- Published
- 2025-04-15
- DOI
- https://doi.org/10.26442/00403660.2025.03.203147
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00